This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related letter  • Related article  • Similar articles in this journal  Topic Collections  • Rheumatology  • Rheumatology, Other  • Immunology  • Immunologic Disorders  • Retinal/ Chorioretinal Disorders  • Alert me on articles by topic

Keye L. Wong, MD, FACS

	Since this article does not have an abstract, we have provided the first 74 words of the full text and any section headings.

Papadaki et al¹ described 2 cases as the first report in which retinal vasculitis secondary to systemic lupus erythematosus (SLE) was successfully treated with plasmapheresis and immunosuppressive therapy. In 1981 we reported a case of SLE retinopathy in which vision improved following the use of plasmapheresis, corticosteroids, and cyclophosphamide.²

AUTHOR INFORMATION
Correspondence: Dr Wong, Sarasota Retina Institute, 3400 Bee Ridge Rd, Sarasota, FL 34239 (klwong101@home.com).

Financial Disclosure: None reported.

1. Papadaki TG, Zacharopoulos IP, Papaliodis G; et al. Plasmapheresis for lupus retinal vasculitis. Arch Ophthalmol. 2006;124(11):1654-1656. FREE FULL TEXT 2. Wong K, Ai E, Jones JV, Young D. Visual loss as the initial symptom of systemic lupus erythematosus. Am J Ophthalmol. 1981;92(2):238-244. ISI | PUBMED

Arch Ophthalmol. 2007;125(8):1142.

RELATED LETTER

Lupus Treated With Plasmapheresis—Reply
C. Stephen Foster
Arch Ophthalmol. 2007;125(8):1142.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Plasmapheresis for Lupus Retinal Vasculitis
Thekla G. Papadaki, Ioannis P. Zacharopoulos, George Papaliodis, Barbara Iaccheri, Tito Fiore, and C. Stephen Foster
Arch Ophthalmol. 2006;124(11):1654-1656.
EXTRACT | FULL TEXT